Profusa Executes 1-for-25 Reverse Stock Split to Boost Share Price
Event summary
- Profusa will implement a 1-for-25 reverse stock split effective July 7, 2026.
- Outstanding shares reduce from ~13.2 million to ~530 thousand post-split.
- Trading continues under ticker PFSA with new CUSIP number 74319X 306.
- Fractional shares will be paid out in cash rather than issued.
The big picture
Profusa’s reverse stock split is a strategic move to meet Nasdaq’s minimum bid price requirement, reflecting broader trends in biotech companies optimizing share structure for market stability. The reduction in outstanding shares may signal confidence in future valuation but could also raise questions about liquidity and investor accessibility.
What we're watching
- Market Perception Shift
- How the reverse split impacts investor confidence and trading liquidity.
- Operational Focus
- Whether reduced share count aligns with Profusa's long-term growth strategy.
- Regulatory Compliance
- The pace at which Nasdaq and SEC approve the structural changes.